Literature DB >> 7138584

Effect of ARA-C incorporation on deoxyribonucleic acid synthesis in cells.

P P Major, E M Egan, D J Herrick, D W Kufe.   

Abstract

Recent work using isolated DNA polymerase-template complexes has shown that arabinofuranosyl derivatives con slow DNA synthesis by being incorporated into DNA. Our results suggest that these agents act by a similar mechanism in L1210 cells. The results demonstrate that inhibition of cellular DNA synthesis by cytosine arabinoside (ara-C) was significantly related to the extent of ara-C incorporation in DNA over a wide range of drug concentrations and times of exposure. Furthermore, treatment with increasing concentrations of ara-C resulted in a greater proportion of ara-C residues at the 3'-terminus of the elongating DNA chain. These observations suggest that ara-C incorporation results in poor primer termini for further chain elongation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138584     DOI: 10.1016/0006-2952(82)90266-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  26 in total

1.  Clusters of S1 nuclease-hypersensitive sites induced in vivo by DNA damage.

Authors:  J Legault; A Tremblay; D Ramotar; M E Mirault
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.

Authors:  R L Momparler; N Onetto-Pothier; D Y Bouffard; L F Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  A comparison of the effects of cytosine arabinoside and beta-lactams on DNA synthesis and cellular proliferation.

Authors:  R J Fram
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

4.  The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.

Authors:  L M Wang; J C White; R L Capizzi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene.

Authors:  A P Stegmann; M W Honders; A Hagemeijer; B Hoebee; R Willemze; J E Landegent
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

6.  Cytosine arabinoside reduces the numbers of granulocyte macrophage colony forming cells (GM-CFC) and high proliferative potential colony forming cells (HPP-CFC) in vivo in mice.

Authors:  Stanley Teleka; Alexander Chijuwa; Edward Senga; John E Chisi
Journal:  Malawi Med J       Date:  2011-12       Impact factor: 0.875

7.  Enhanced retention of cytosine arabinoside and its metabolites and synergistic cytotoxicity by sequential treatment with dipyridamole in L5178Y leukemia.

Authors:  J L Yang; J C White; R L Capizzi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.

Authors:  J Zittoun; J Marquet; J C David; D Maniey; R Zittoun
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  Potentiation of etoposide-induced cytotoxicity and DNA damage in CCRF-CEM cells by pretreatment with non-cytotoxic concentrations of arabinosyl cytosine.

Authors:  C M Chresta; R Hicks; J A Hartley; R L Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  A phase I-II study of combination therapy with thymidine and cytosine arabinoside.

Authors:  R Fram; P Major; E Egan; P Beardsley; D Rosenthal; D Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.